ABSTRACT
Importance: Most people with dementia will experience neuropsychiatric symptoms, including psychosis characterized by hallucinations and delusions. Across dementia subtypes, hallucinations and delusions are common, though their prevalence and presentation may vary. These symptoms have been associated with worse outcomes compared with dementia alone, including accelerated functional decline and mortality. Many people with dementia reside in long-term care facilities, and identification and management of hallucinations and delusions in this setting are critical.Observations: For residents in long-term care facilities, the following factors can hinder management of hallucinations and delusions related to dementia: (1) delayed recognition of symptoms; (2) reluctance of staff and family members to acknowledge psychiatric issues; (3) lack of approved pharmacotherapies to treat hallucinations and delusions associated with dementia-related psychosis; and (4) regulatory and institutional guidelines, including the long-term care regulatory guidelines established by the Centers for Medicare and Medicaid Services and the 5-star rating system.Conclusions and Relevance: Barriers to the treatment of hallucinations and delusions in patients with dementia in the long-term care setting are myriad and complex. Early diagnosis of dementia-related psychosis and new treatment options for managing hallucinations and delusions are needed to improve care of this patient population.
Subject(s)
Dementia , Psychotic Disorders , Aged , Delusions/diagnosis , Delusions/etiology , Delusions/therapy , Dementia/complications , Dementia/diagnosis , Dementia/therapy , Hallucinations/diagnosis , Hallucinations/etiology , Hallucinations/therapy , Humans , Long-Term Care , Medicare , Psychotic Disorders/complications , Psychotic Disorders/diagnosis , United StatesABSTRACT
Introduction Psychiatric illness impacts nearly one-quarter of the US population. Few studies have evaluated the impact of psychiatric illness on in-hospital trauma patient care. In this study, we conducted a retrospective cohort study to evaluate hospital resource utilization for trauma patients with comorbid psychiatric illnesses. Methodology Trauma patients admitted to a level I center over a one-year period were included in the study. Patients were categorized into one of three groups: (1) no psychiatric history or in-hospital psychiatric service consultation; (2) psychiatric history but no psychiatric service consultation; and (3) psychiatric service consultation. Time to psychiatric service consultation was calculated and considered early if occurring on the day of or the day following admission. Patient demographics, outcomes, and resource utilization were compared between the three groups. Results A total of 1,807 patients were included in the study (n = 1,204, 66.6% no psychiatric condition; n = 508, 28.1% psychiatric condition without in-hospital psychiatric service consultation; and n = 95, 5.3% in-hospital psychiatric service consultation). Patients requiring psychiatric service consultation were the youngest (P < .001), with the highest injury severity (P = .024), the longest hospital length of stay (P < .001), and the highest median hospital cost (P < .001). Early psychiatric service consultation was associated with an average saving in-hospital length of stay of 2.9 days (P = .021) and an average hospital cost saving of $7,525 (P = .046). Conclusion One-third of our trauma population had an existing psychiatric diagnosis or required psychiatric service consultation. Resource utilization was higher for patients requiring consultation. Early consultation was associated with a savings of hospital length of stay and cost.
Subject(s)
Hallucinogens , Psilocybin , Injections, Intravenous , Intensive Care Units , Psilocybin/adverse effectsSubject(s)
Amphetamine-Related Disorders/complications , Cellulitis/complications , Central Nervous System Stimulants/administration & dosage , Facial Injuries/complications , Fractures, Bone/complications , Methamphetamine/administration & dosage , Nasal Bone/injuries , Administration, Intranasal , Humans , Male , Middle Aged , Solutions , ViolenceSubject(s)
Heroin Dependence , Heroin/administration & dosage , Inpatients , Administration, Intranasal , Female , Hospitalization , Humans , Young AdultSubject(s)
Anti-N-Methyl-D-Aspartate Receptor Encephalitis/complications , beta-Thalassemia/complications , Anti-N-Methyl-D-Aspartate Receptor Encephalitis/immunology , Anti-N-Methyl-D-Aspartate Receptor Encephalitis/therapy , Biomarkers , Child , Female , Humans , beta-Thalassemia/immunology , beta-Thalassemia/therapyABSTRACT
BACKGROUND: Descriptions of malingering imposed on another, in which an individual induces or exaggerates symptoms in another for secondary gain (including financial benefit or access to medications), are remarkably scant in the current literature. We summarize reported cases of malingering imposed on another in order to underscore its relevance to practicing physicians. OBJECTIVE: We sought to review the available literature describing the creation or exaggeration of symptoms of illness, motivated by secondary gain, in another vulnerable individual. METHOD: A search of the literature using PubMed was undertaken searching the terms "malingering," "by proxy," and "imposed on another." RESULTS: Malingering imposed on another may be under-reported in the professional literature. Maintaining awareness that caregivers may misrepresent or embellish the symptoms of the identified patient for their own gain is an important consideration to forestall unnecessary testing, hospital admission, and exposure to adverse effects of treatments.
Subject(s)
Malingering/diagnosis , Munchausen Syndrome by Proxy/diagnosis , Caregivers , HumansSubject(s)
Codeine/analogs & derivatives , Skin Diseases, Bacterial/diagnosis , Substance Abuse, Intravenous/complications , Adult , Amphetamine-Related Disorders/complications , Codeine/adverse effects , Diagnosis, Differential , Female , Heroin Dependence/complications , Humans , Skin Diseases, Bacterial/etiologySubject(s)
Encephalomalacia , Foreign Bodies , Frontal Lobe , Lead Poisoning, Nervous System, Adult , Wounds, Gunshot , Adult , Humans , MaleABSTRACT
BACKGROUND: Distinguishing epileptic seizures from nonepileptic seizures (NES) can be difficult, given their similar motoric manifestations and a common comorbidity. Although video electroencephalography in an epilepsy monitoring unit ideally remains the gold standard for the identification of NES, a number of "soft signs" have been proposed to indicate a greater likelihood that convulsive episodes are NES rather than epileptic in nature. Trainees at our institution have cited the presence of multiple listed allergies as indicative of a higher likelihood of NES. OBJECTIVE: The goal of this study was to provide a statistical analysis of polyallergy and its association with patients with NES admitted for video electroencephalograph monitoring. METHODS: Records of all epilepsy monitoring unit patients at St. Joseph's Hospital and Medical Center between 2006 and 2012 were reviewed for age, sex, electroencephalograph diagnosis, antiepileptic drugs previously tried, and allergy number. RESULTS: A total of 1834 patient records were used for analysis. The group classified as nonepileptic had the highest average number of allergies at 1.56, whereas the group classified as epileptic had the lowest average number of allergies at 0.70. A logistic regression model revealed that for every increase in the number of allergies greater than zero, the odds of being nonepileptic increases by 1.38 times. CONCLUSIONS: This study supports polyallergy as a predictive sign for NES. Based on a logistic regression model, we claim that each additional allergy is associated with an increase in the likelihood of a nonepileptic diagnosis by 38%.